Related Experiment Video
Updated: Oct 26, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Emerging roles of miRNAs in the development of pancreatic cancer
Mohadeseh Fathi1, Soudeh Ghafouri-Fard1, Atefe Abak2
1Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:
Pancreatic cancer is a fatal cancer which is expected to exceed breast cancer as the third foremost source of cancer mortality by 2025. This cancer has been associated with several somatic genetic aberrations including mutations in the KRAS, CDKN2A/p16, TP53, and SMAD4. In addition, epigenetic alterations have been shown to affect development of this cancer. miRNAs are among the mostly appreciated epigenetic factors in this regard. Several oncomiRs such as miR-212, miR 506, miR-196b, miR-221-3p, miR-301a-3p, miR-23a and miR-29a have been found to promote proliferation of pancreatic cancer cells and block apoptotic pathways in these cells. On the other hand, miR-451a, miR-506, miR-142, miR-216b, miR-519d-3p, miR-1181, miR-340, miR-143-3p, miR-203a-3p, miR-455, miR-15a, miR-135a and miR-202 are among tumor suppressor miRNAs that modulate proliferation and cell cycle transition in these cells. In the current paper, we will discuss the role of oncomiRs and tumor suppressor miRNAs in the evolution of pancreatic cancer. Moreover, we will summarize the application of miRNAs as diagnostic and prognostic markers in pancreatic cancer. These studies have shown the ability of miRNAs to be served as non-invasive markers for pancreatic cancer.
Insights
MicroRNAs (miRNAs) play a dual role in pancreatic cancer, with some promoting tumor growth and others suppressing it. These epigenetic factors show promise as non-invasive diagnostic and prognostic markers for pancreatic cancer.
Area of Science:
- * Molecular Oncology
- * Epigenetics
- * Cancer Biology
Background:
- * Pancreatic cancer is a leading cause of cancer mortality, projected to become the third leading cause by 2025.
- * Genetic mutations (KRAS, TP53, etc.) and epigenetic alterations drive pancreatic cancer development.
- * MicroRNAs (miRNAs) are key epigenetic regulators implicated in various cancers, including pancreatic cancer.
Purpose of the Study:
- * To elucidate the dual role of oncomiRs and tumor suppressor miRNAs in pancreatic cancer evolution.
- * To review the diagnostic and prognostic potential of miRNAs in pancreatic cancer.
- * To highlight miRNAs as potential non-invasive biomarkers for early detection and patient management.
Main Methods:
- * Comprehensive literature review of studies investigating miRNA roles in pancreatic cancer.
- * Analysis of identified oncomiRs and tumor suppressor miRNAs affecting cancer cell proliferation and apoptosis.
- * Evaluation of miRNA expression profiles for diagnostic and prognostic applications.
Main Results:
- * Specific oncomiRs (e.g., miR-212, miR-506, miR-196b) promote pancreatic cancer cell proliferation and inhibit apoptosis.
- * Tumor suppressor miRNAs (e.g., miR-451a, miR-142, miR-340) modulate cell proliferation and cell cycle progression.
- * miRNAs demonstrate potential as sensitive and specific non-invasive biomarkers for pancreatic cancer detection and prognosis.
Conclusions:
- * MicroRNAs are critical epigenetic regulators in pancreatic cancer, acting as both oncomiRs and tumor suppressors.
- * Dysregulation of specific miRNAs contributes to pancreatic cancer pathogenesis.
- * miRNAs hold significant promise as novel, non-invasive diagnostic and prognostic tools for pancreatic cancer, facilitating earlier detection and improved patient outcomes.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

